Compare the Pharmacokinetics of NVP-1805 and Coadministration of NVP-1805-R1 With NVP-1805-R2

计划入组 58 人 · 首次发布于 2021 年 3 月 3 日

NVP-1805 Compared to Coadministration of NVP-1805-R1 With NVP-1805-R2 in Healthy Adult Volunteers

计划入组 58 人 · 首次发布于 2021 年 5 月 27 日

NVP-1805 Compared to Coadministration of NVP-1805-R1 With NVP-1805-R2 in Healthy Adult Volunteers (BE)

计划入组 58 人 · 首次发布于 2022 年 4 月 29 日

NVP-2002

NVP-2203

NVP-2102

Incannex Healthcare

Australia

Sensus Healthcare

United States

Wellspect Healthcare

United States

NVP Healthcare Advances Oral Treatment NVP-1805R2 for Cardiovascular Disorders

Novartis Unveils NVP-FVP954: A Novel IV Antimalarial for Severe Malaria

Novartis' NLRP3 Inhibitor NVP-DFV890 Advances in Phase II Trials for Coronary Heart Disease and Osteoarthritis